Literature DB >> 12378100

Gamma knife radiosurgery for growth hormone-secreting pituitary adenomas invading the cavernous sinus.

S Fukuoka1, T Ito, M Takanashi, A Hojo, H Nakamura.   

Abstract

The authors assessed whether gamma knife radiosurgery is effective for patients with acromegaly where the pituitary tumors invaded the cavernous sinus. Radiosurgery was performed on 9 patients (average of 20 Gy to the tumor margin), 8 of whom had already undergone transsphenoidal surgery and/or craniotomy with occasional medication of octreotide to reduce tumor size as well as hormonal levels. All tumors have been well controlled so far with follow-up periods ranging from 12 to 69 months (mean: 42). No complications occurred. Forty percent of the patients showed hormonal normalization at 2 years, with the median being 31 months. Similarly, 50% of the patients demonstrated normalization of GH and IGF-I at 36 months. We conclude that gamma knife radiosurgery is a safe and effective tool to treat these tumors invading the cavernous sinus. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12378100     DOI: 10.1159/000066721

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  10 in total

1.  Gamma knife radiosurgery for clinically persistent acromegaly.

Authors:  Xiaomin Liu; Hideyuki Kano; Douglas Kondziolka; Kyung-Jae Park; Aditya Iyer; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

Review 2.  Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy.

Authors:  Dale Ding; Robert M Starke; Jason P Sheehan
Journal:  J Neurooncol       Date:  2014-05       Impact factor: 4.130

Review 3.  Cranial stereotactic radiosurgery: current status of the initial paradigm shifter.

Authors:  Jason P Sheehan; Chun-Po Yen; Cheng-Chia Lee; Jay S Loeffler
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

4.  Stereotactic radiosurgery in pituitary adenomas: long-term single institution experience and role of the hypothalamic-pituitary axis.

Authors:  Kita Sallabanda; Sergey Usychkin; Fernando Puebla; José C Bustos; José A Gutiérrez-Diaz; Carmen Peraza; César Beltrán; Hugo Marsiglia; José Samblás
Journal:  J Radiosurg SBRT       Date:  2011

5.  Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.

Authors:  Hiromitsu Iwata; Kengo Sato; Ryutaro Nomura; Yusuke Tabei; Ichiro Suzuki; Naoki Yokota; Mitsuhiro Inoue; Seiji Ohta; Shozo Yamada; Yuta Shibamoto
Journal:  J Neurooncol       Date:  2016-03-09       Impact factor: 4.130

Review 6.  Stereotactic radiosurgery for pituitary adenomas: a review of the literature.

Authors:  Edward R Laws; Jason P Sheehan; Jonas M Sheehan; Jay Jagnathan; John A Jane; Rod Oskouian
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

7.  Gamma Knife robotic microradiosurgery of pituitary adenomas invading the cavernous sinus: treatment concept and results in 89 cases.

Authors:  Motohiro Hayashi; Mikhail Chernov; Noriko Tamura; Mariko Nagai; Shoji Yomo; Taku Ochiai; Kosaku Amano; Masahiro Izawa; Tomokatsu Hori; Yoshihiro Muragaki; Hiroshi Iseki; Yoshikazu Okada; Kintomo Takakura
Journal:  J Neurooncol       Date:  2010-04-22       Impact factor: 4.130

8.  Surgical results of growth hormone-secreting pituitary adenoma.

Authors:  Min-Su Kim; Hyun-Dong Jang; Oh-Lyong Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-05-31

Review 9.  Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife.

Authors:  Jay Jagannathan; Chun-Po Yen; Nader Pouratian; Edward R Laws; Jason P Sheehan
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

10.  Gamma knife radiosurgery for acromegaly.

Authors:  John D Rolston; Lewis S Blevins
Journal:  Int J Endocrinol       Date:  2012-02-13       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.